ORALONE Drug Patent Profile
When do Oralone patents expire, and what generic alternatives are available?
Oralone is a drug marketed by Sun Pharma Canada and is included in one NDA.
The generic ingredient in ORALONE is triamcinolone acetonide. There is one drug master file entry for this compound. Eighty suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oralone
A generic version of ORALONE was approved as triamcinolone acetonide by SUN PHARMA CANADA on October 1st, 1986.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ORALONE?
- What are the global sales for ORALONE?
- What is Average Wholesale Price for ORALONE?
Summary for ORALONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 82 |
| Patent Applications: | 4,797 |
| Drug Prices: | Drug price information for ORALONE |
| DailyMed Link: | ORALONE at DailyMed |
US Patents and Regulatory Information for ORALONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma Canada | ORALONE | triamcinolone acetonide | PASTE;DENTAL | 071383-001 | Jul 6, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
